Macrocure Announces Annual General Meeting of Shareholders
December 09, 2015 09:26 ET
|
Macrocure
PETACH TIKVA, Israel, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (NASDAQ:MCUR), a clinical-stage biotechnology company, today announced that it will hold its Annual General Meeting of...
Macrocure Ltd. Reports Changes to Senior Management and the Board of Directors
November 27, 2015 13:05 ET
|
Macrocure
PETACH TIKVA, Israel, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or the "Company") (NASDAQ:MCUR), today announced that as the Company continues to explore potential strategic...
Macrocure Ltd. Reports Third Quarter 2015 Financial Results
November 17, 2015 16:05 ET
|
Macrocure
PETACH TIKVA, Israel, Nov. 17, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or the "Company") (NASDAQ:MCUR), today provided a corporate update and reported financial results for the third...
Macrocure Ltd. Announces Results for Phase III Clinical Trial of CureXcell(R) in Diabetic Foot Ulcers and Provides Corporate Update
October 27, 2015 17:20 ET
|
Macrocure
PETACH TIKVA, Israel, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or the "Company") (NASDAQ:MCUR), a clinical-stage biotechnology company focused on advancing its novel therapeutic...
Macrocure Ltd. Provides Update on Futility Analysis for Phase III Clinical Trial of CureXcell(R) in Venous Leg Ulcers
August 19, 2015 18:40 ET
|
Macrocure
PETACH TIKVA, Israel, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or the "Company") (NASDAQ:MCUR), a clinical-stage biotechnology company focused on advancing its novel therapeutic...
Macrocure Ltd. Provides Corporate Update and Reports Second Quarter 2015 Financial Results
August 04, 2015 16:05 ET
|
Macrocure
—Company to Report VLU Futility Analysis Results in the Second Half of August 2015—
—Company to Report Top Line Results From Its Phase III Diabetic Foot Ulcer (DFU) in October...
Macrocure Ltd. Announces Second Quarter 2015 Financial Results Date and Conference Call
July 22, 2015 08:00 ET
|
Macrocure
PETACH TIKVA, Israel, July 22, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (NASDAQ:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. to Present at the Jefferies 2015 Global Healthcare Conference
May 29, 2015 08:00 ET
|
Macrocure
PETACH TIKVA, Israel, May 29, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. Provides Corporate Update and Reports First Quarter 2015 Financial Results
May 11, 2015 16:05 ET
|
Macrocure
PETACH TIKVA, Israel, May 11, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. ("Macrocure" or "the Company") (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic...
Macrocure Files Annual Report on Form 20-F for the Year Ended December 31, 2014
May 04, 2015 16:05 ET
|
Macrocure
PETACH TIKVA, Israel, May 4, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...